New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 25, 2013
10:01 EDTSAPMY, VET, TIVO, NFLX, MYL, SUBCY, VIAB, TEVA, NGL, HASI, WAGE, LCI, TWX, STRZA, KYTH, DTV, ACT, DISCA, FOXA, DIS, DISHOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 21st Century Fox (FOXA) initiated with an Outperform at FBR Capital... Actavis (ACT) initiated with a Buy at Citigroup.... DISH (DISH) initiated with an Underperform at FBR Capital... DirecTV (DTV) initiated with a Market Perform at FBR Capital... Discovery (DISCA) initiated with an Outperform at FBR Capital... Disney (DIS) initiated with an Outperform at FBR Capital... Hannon Armstrong (HASI) initiated with a Sector Perform at RBC Capital... Kythera (KYTH) initiated with a Buy at BofA/Merrill... Mylan (MYL) initiated with a Neutral at Citigroup... NGL Energy Partners (NGL) initiated with an Outperform at Raymond James... Netflix (NFLX) initiated with a Market Perform at FBR Capital... Starz (STRZA) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with a Buy at Citigroup... TiVo (TIVO) initiated with a Market Perform at FBR Capital... Time Warner (TWX) initiated with an Outperform at FBR Capital... Vermilion Energy (VET) initiated with a Neutral at Goldman... Viacom (VIAB) initiated with an Outperform at FBR Capital... Lannett (LCI) initiated with a Buy at BofA/Merrill... Subsea 7 (SUBCY) initiated with a Buy at Canaccord... Saipem (SAPMY) initiated with a Hold at Canaccord... WageWorks (WAGE) initiated with a Buy at SunTrust.
News For FOXA;ACT;DISH;DISCA;DTV;DIS;HASI;MYL;KYTH;NGL;NFLX;STRZA;TEVA;TIVO;TWX;VIAB;VET;LCI;SUBCY;SAPMY;WAGE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
February 23, 2015
09:59 EDTDTVOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Antofagasta (ANFGY) downgraded to Sell from Neutral at Goldman... Arch Coal (ACI) downgraded to Sell from Buy at Argus... BHP Billiton (BHP) downgraded to Equal Weight from Overweight at Morgan Stanley... Beazer Homes (BZH) downgraded to Neutral from Buy at Compass Point... Boeing (BA) downgraded to Sell from Neutral at Goldman... Century Communities (CCS) downgraded to Neutral from Overweight at JPMorgan... CyberArk (CYBR) downgraded to Underweight from Neutral at JPMorgan... DirecTV (DTV) downgraded to Hold from Buy at Brean Capital... Enerplus (ERF) downgraded to Hold from Buy at Desjardins... Fiserv (FISV) downgraded to Neutral from Buy at Monness Crespi... GP Strategies (GPX) downgraded to Neutral from Buy at B. Riley... Interactive Brokers (IBKR) downgraded to Market Perform at Keefe Bruyette... MRC Global (MRC) downgraded at BB&T... Precision Castparts (PCP) downgraded to Neutral from Buy at Goldman... Quest Diagnostics (DGX) downgraded at BofA/Merrill... Rio Tinto (RIO) downgraded to Equal Weight from Overweight at Morgan Stanley... Roth Capital downgraded Spectrum (SPPI) on court case loss... Royal Dutch Shell (RDS.A) downgraded to Sector Perform from Outperform at Howard Weil... Ryland Group (RYL) downgraded to Neutral from Buy at Compass Point... Salix (SLXP) downgraded to Market Perform from Outperform at Leerink... Standard Pacific (SPF) downgraded to Neutral from Buy at Compass Point... Superior Energy (SPN) downgraded to Neutral from Outperform at Credit Suisse... Transocean (RIG) downgraded to Negative from Neutral at Susquehanna... Vale (VALE) downgraded to Equal Weight from Overweight at Morgan Stanley.
09:12 EDTFOXA, DISCADiscovery volatility flat into 21st Century Fox denied it held talks
Subscribe for More Information
08:55 EDTFOXAFox News' O'Reilly defending statements, NY Times reports
Subscribe for More Information
08:33 EDTVIAB, FOXA'Fifty Shades' ticket sales retain top spot at box office, Reuters says
Subscribe for More Information
07:38 EDTTWX, DTVComcast, AT&T deals could be delayed by document access case, WSJ says
Subscribe for More Information
07:16 EDTMYLMylan signs exclusive agreement with Gilead to distribute Solvaldi, Harvoni
Subscribe for More Information
07:00 EDTDISCA, FOXA21st Century Fox says 'no truth' in rumors of Discovery talks, Reuters reports
Subscribe for More Information
06:34 EDTDISCA, FOXA21st Century Fox, Discovery held preliminary merger talks, AFR reports
21st Century Fox (FOXA) executives met with their counterparts at Discovery Communications (DISCA) nearly two weeks ago to discuss a possible takeover offer, The Australian Financial Review reports, citing sources. According to the sources, discussions were "nascent" and talks are in the "very, very early days." A spokesperson for 21st Century Fox has denied talks took place. Reference Link
06:08 EDTDISHDISH reports 2.6M activations of gorss new PAy-TV subscribers
Subscribe for More Information
06:07 EDTDISHDISH reports FY14 EPS $2.04, consensus $1.59
Reports FY14 revenue $14.6B, consensus $14.66B
06:06 EDTDISHDISH announces President and CEO Joseph Clayton to retire March 31, 2015
Subscribe for More Information
05:33 EDTDTVDirecTV downgraded to Hold from Buy at Brean Capital
Subscribe for More Information
February 22, 2015
13:03 EDTDISDisney raises prices at the Magic Kingdom, Orlando Sentinel says
Subscribe for More Information
February 20, 2015
13:56 EDTDISHAT&T VP critical of Dish auction tactics
AT&T (T) VP of Federal Regulatory Joan Marsh stated in a post to a corporate blog that FCC Auction 97 represents "hard evidence that there is significant continuing interest in licensed spectrum... It didn't matter that it was mid-band spectrum. It mattered only that it was broadband spectrum." Marsh notes that Dish (DISH) won more licenses than any other bidder though "none of that spectrum is currently supporting commercial wireless services," with her suggestion being that "auctions should be designed to ensure that licenses go to those willing to deploy networks – not speculators or stockpilers...The government should continue to place a high priority on allocating new licensed bands to the wireless industry." Marsh continues her analysis of Dish, claiming the double and triple-bidding activity carried out by its two designated entities "circumvented auction activity rules, masked actual demand and distorted the auction," as they were able to win significant allocations while enjoying a 25% small business discount. In response to Dish claims that all companies use DEs, Marsh replies that "in more recent auctions... bidders like AT&T, Verizon (VZ) and T-Mobile (TMUS) had no DE relationships, participated directly and paid full price for their licenses." Reference Link
10:01 EDTDTVOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:46 EDTACTActavis receives final approval for generic version of Subutex
Actavis announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Reckitt Benckiser's Subutex. Actavis intends to begin shipping its product shortly. Subutex is indicated for the treatment of opioid dependence. For the 12 months ending December 31, 2014, Subutex had total U.S. sales of approximately $108M, according to IMS Health data.
08:07 EDTACTActavis price target raised to $340 from $310 at Argus
Argus increased its price target on Actavis as the firm believes that the company is generating strong growth. Argus is upbeat on the company's acquisition of Allergan and keeps a Buy rating on the shares.
08:04 EDTTEVATeva to present new respiratory data at AAAAI
Teva Pharmaceutical Industries announced that four company-sponsored abstracts will be presented at the 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology, or AAAAI, in Houston, Texas. Data to be presented include two replicate 52-week Phase III global studies of the company’s anti-IL5 monoclonal antibody, reslizumab, in patients with asthma and elevated blood eosinophils who were inadequately controlled on medium-to-high doses of inhaled corticosteroids with or without an additional controller. The data are scheduled for presentation on Monday, February 23 during an oral session titled “Asthma Therapy and Mechanisms.” Also to be presented are two Phase III studies of beclomethasone dipropionate 40mcg, which gained FDA approval in December 2014, and is now available for the treatment of nasal symptoms associated with allergic rhinitis in children 4-11 years of age. In addition, a dose-response study evaluating the safety and efficacy of fluticasone/salmeterol multidose dry-powder inhaler in patients 12 years of age and older with persistent asthma will be presented.
07:40 EDTDTVDirecTV downgraded to Neutral from Buy at Buckingham
Buckingham downgraded DirecTV (DTV) to Neutral based on lack of sufficient upside from the AT&T (T) transaction and views risk/reward as balanced at current levels. Price target lowered to $92 from $95.
07:08 EDTMYL, TEVAAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use